Literature DB >> 19001073

Secreted antibody is required for immunity to Plasmodium berghei.

Julia K Nunes1, Michael N Starnbach, Dyann F Wirth.   

Abstract

Infection with Plasmodium berghei is lethal to mice, causing high levels of parasitemia, severe anemia, and death. However, when mice are treated with antimalarial drugs during acute infection, they have enhanced immunity to subsequent infections. With this infection and cure model of immunity, we systematically examined the basis of adaptive immunity to infection using immunodeficient mice. In order to induce adaptive immunity, mice were infected with blood-stage parasites. When the mice developed 2 to 3% parasitemia, they were treated with chloroquine to cure the infection. These convalescent mice were then challenged with homologous blood-stage parasites. Immunized wild-type mice were able to control the level of infection. In contrast, mice lacking mature B cells and T cells were unable to control a challenge infection, indicating the critical role of lymphocytes in immunity to P. berghei. Furthermore, mice lacking secreted antibody were unable to control the level of parasitemia following a challenge infection. Our results indicate that secreted antibody is a requirement for immunity to P. berghei.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001073      PMCID: PMC2612237          DOI: 10.1128/IAI.00982-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells.

Authors:  L A Cavacini; C A Long; W P Weidanz
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Plasmodium yoelii: antibody and the maintenance of immunity in BALB/c mice.

Authors:  R R Freeman; C R Parish
Journal:  Exp Parasitol       Date:  1981-08       Impact factor: 2.011

3.  Active immunization against Plasmodium berghei malaria in mice.

Authors:  M L Weiss; D L De Giusti
Journal:  Am J Trop Med Hyg       Date:  1966-07       Impact factor: 2.345

4.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

5.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection.

Authors:  A W Taylor-Robinson; R S Phillips
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

7.  Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line.

Authors:  D A Brake; C A Long; W P Weidanz
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

Review 8.  Immunity to erythrocytic stages of malarial parasites.

Authors:  C A Long; T M Daly; P Kima; I Srivastava
Journal:  Am J Trop Med Hyg       Date:  1994       Impact factor: 2.345

9.  Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.

Authors:  J M Vinetz; S Kumar; M F Good; B J Fowlkes; J A Berzofsky; L H Miller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  8 in total

Review 1.  Animal models of anemia of inflammation.

Authors:  Seth Rivera; Tomas Ganz
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

2.  Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.

Authors:  Suci Nuralitha; Josephine E Siregar; Din Syafruddin; Jessica Roelands; Jan Verhoef; Andy I M Hoepelman; Sangkot Marzuki
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

3.  Curcumin-arteether combination therapy of Plasmodium berghei-infected mice prevents recrudescence through immunomodulation.

Authors:  Palakkod G Vathsala; Chaitanya Dende; Viswanathan Arun Nagaraj; Debapriya Bhattacharya; Gobardhan Das; Pundi N Rangarajan; Govindarajan Padmanaban
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

4.  Assessment of in vivo antimalarial activity of arteether and garlic oil combination therapy.

Authors:  Vathsala Palakkod Govindan; Aditya Nayak Panduranga; P Krishna Murthy
Journal:  Biochem Biophys Rep       Date:  2016-01-24

5.  Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.

Authors:  Leanne M Low; Aloysious Ssemaganda; Xue Q Liu; Mei-Fong Ho; Victoria Ozberk; James Fink; Lana Sundac; Kylie Alcorn; Amy Morrison; Kevin O'Callaghan; John Gerrard; Danielle I Stanisic; Michael F Good
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

6.  CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model.

Authors:  Lam Quoc Bao; Nguyen Tien Huy; Mihoko Kikuchi; Tetsuo Yanagi; Masachika Senba; Mohammed Nasir Shuaibu; Kiri Honma; Katsuyuki Yui; Kenji Hirayama
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

7.  Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection.

Authors:  Alvaro Baeza Garcia; Edwin Siu; Tiffany Sun; Valerie Exler; Luis Brito; Armin Hekele; Gib Otten; Kevin Augustijn; Chris J Janse; Jeffrey B Ulmer; Jürgen Bernhagen; Erol Fikrig; Andrew Geall; Richard Bucala
Journal:  Nat Commun       Date:  2018-07-13       Impact factor: 14.919

8.  Ensemble modeling highlights importance of understanding parasite-host behavior in preclinical antimalarial drug development.

Authors:  Lydia Burgert; Matthias Rottmann; Sergio Wittlin; Nathalie Gobeau; Andreas Krause; Jasper Dingemanse; Jörg J Möhrle; Melissa A Penny
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.